Furthermore, Mortensen et al. showed that expression of immunoreactive eNOS in the peritumoral microvasculature is a favorable prognostic indicator in premenopausal breast cancer patients, providing clinical evidence for a defensive role of eNOS against cancer cells [27]. The gene discussed is NOS3; the disease is cancer.